polygenic risk score
Data from Myriad Genetics offered early validation evidence for an expanded version of its commercial test, as well as a look into clinical impact via claims data.
Biobanks have been making strides in gathering data from more diverse populations this year while the evidence for the clinical utility of embryo PRS testing remains insufficient.
Genetic Technologies, Stayhealthy Ink US Distribution Deal for Multi-Disease Risk Test
Genetic Technologies said that it will offer its test for the risk of cancers and other chronic diseases through Stayhealthy's online discount pharmacy.
ACMG Asserts Evidence Insufficient for Clinical Utility of Polygenic Risk Scores for Embryo Testing
Premium
The risk of harm to prospective parents or future children outweighs the benefits of preimplantation genetic testing, an ACMG working group said.
GenInCode Files FDA 510(k) Submission For Polygenic Cardiovascular Disease Risk Test
The test recently received a CPT PLA code and is currently offered through GenInCode's laboratory in Irvine, California.